164 related articles for article (PubMed ID: 21910160)
1. SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.
Peterson EA; Stanbery L; Li C; Kocak H; Makarova O; Petty EM
Genes Chromosomes Cancer; 2011 Nov; 50(11):940-9. PubMed ID: 21910160
[TBL] [Abstract][Full Text] [Related]
2. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
[TBL] [Abstract][Full Text] [Related]
3. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.
Gonzalez ME; Peterson EA; Privette LM; Loffreda-Wren JL; Kalikin LM; Petty EM
Cancer Res; 2007 Sep; 67(18):8554-64. PubMed ID: 17875694
[TBL] [Abstract][Full Text] [Related]
4. High SEPT9_i1 protein expression is associated with high-grade prostate cancers.
Gilad R; Meir K; Stein I; German L; Pikarsky E; Mabjeesh NJ
PLoS One; 2015; 10(4):e0124251. PubMed ID: 25898316
[TBL] [Abstract][Full Text] [Related]
5. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
Golan M; Mabjeesh NJ
Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
[TBL] [Abstract][Full Text] [Related]
6. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
Verdier-Pinard P; Salaun D; Bouguenina H; Shimada S; Pophillat M; Audebert S; Agavnian E; Coslet S; Charafe-Jauffret E; Tachibana T; Badache A
Sci Rep; 2017 Mar; 7():44976. PubMed ID: 28338090
[TBL] [Abstract][Full Text] [Related]
7. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
Vardi-Oknin D; Golan M; Mabjeesh NJ
PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission.
Estey MP; Di Ciano-Oliveira C; Froese CD; Bejide MT; Trimble WS
J Cell Biol; 2010 Nov; 191(4):741-9. PubMed ID: 21059847
[TBL] [Abstract][Full Text] [Related]
9. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint.
Privette LM; Weier JF; Nguyen HN; Yu X; Petty EM
Neoplasia; 2008 Jul; 10(7):643-52. PubMed ID: 18592005
[TBL] [Abstract][Full Text] [Related]
10. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
Tazat K; Schindler S; Depping R; Mabjeesh NJ
Cytoskeleton (Hoboken); 2019 Jan; 76(1):123-130. PubMed ID: 29742803
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of nuclear translocation of hypoxia-inducible factor-1α in influenza A (H1N1) virus infected-alveolar epithelial cells].
Meng X; Guo X; Zhu Y; Xie H; Wang R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):8-13. PubMed ID: 32148224
[TBL] [Abstract][Full Text] [Related]
12. Properties of SEPT9 isoforms and the requirement for GTP binding.
Robertson C; Church SW; Nagar HA; Price J; Hall PA; Russell SE
J Pathol; 2004 May; 203(1):519-27. PubMed ID: 15095474
[TBL] [Abstract][Full Text] [Related]
13. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
Golan M; Mabjeesh NJ
Cell Cycle; 2013 Jul; 12(14):2297-308. PubMed ID: 24067372
[TBL] [Abstract][Full Text] [Related]
14. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
[TBL] [Abstract][Full Text] [Related]
15. Septin filament coalignment with microtubules depends on SEPT9_i1 and tubulin polyglutamylation, and is an early feature of acquired cell resistance to paclitaxel.
Targa B; Klipfel L; Cantaloube I; Salameh J; Benoit B; Poüs C; Baillet A
Cell Death Dis; 2019 Jan; 10(2):54. PubMed ID: 30670682
[TBL] [Abstract][Full Text] [Related]
16. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.
Amir S; Golan M; Mabjeesh NJ
Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014
[TBL] [Abstract][Full Text] [Related]
17. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.
Connolly D; Hoang HG; Adler E; Tazearslan C; Simmons N; Bernard VV; Castaldi M; Oktay MH; Montagna C
Biol Chem; 2014 Feb; 395(2):157-67. PubMed ID: 24127542
[TBL] [Abstract][Full Text] [Related]
18. SEPT9 occupies the terminal positions in septin octamers and mediates polymerization-dependent functions in abscission.
Kim MS; Froese CD; Estey MP; Trimble WS
J Cell Biol; 2011 Nov; 195(5):815-26. PubMed ID: 22123865
[TBL] [Abstract][Full Text] [Related]
19. Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions.
Marcus J; Bejerano-Sagie M; Patterson N; Bagchi S; Verkhusha VV; Connolly D; Goldberg GL; Golden A; Sharma VP; Condeelis J; Montagna C
Oncogene; 2019 Jul; 38(30):5839-5859. PubMed ID: 31285548
[TBL] [Abstract][Full Text] [Related]
20. Expression of the SEPT9_i4 isoform confers resistance to microtubule-interacting drugs.
Chacko AD; McDade SS; Chanduloy S; Church SW; Kennedy R; Price J; Hall PA; Russell SE
Cell Oncol (Dordr); 2012 Apr; 35(2):85-93. PubMed ID: 22278362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
